Status:

COMPLETED

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

Lead Sponsor:

Novartis

Conditions:

Osteoarthritis of the Knee

Eligibility:

All Genders

35+ years

Phase:

PHASE3

Brief Summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.

Eligibility Criteria

Inclusion

  • Osteoarthritis of the knee

Exclusion

  • Other rheumatic disease, such as rheumatoid arthritis
  • Active gastrointestinal ulcer during the last year
  • Known allergy to analgesic drugs
  • Other protocol defined inclusion/exclusion criteria may apply.

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2007

Estimated Enrollment :

420 Patients enrolled

Trial Details

Trial ID

NCT00426621

Start Date

November 1 2006

End Date

June 1 2007

Last Update

December 18 2007

Active Locations (64)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 16 (64 locations)

1

Coastal Clinical Research Inc

Mobile, Alabama, United States, 33608

2

River Region Research, LLC

Tallassee, Alabama, United States, 36078

3

East Valley Family Physicians

Chandler, Arizona, United States, 85224

4

HOPE Research Institute

Phoenix, Arizona, United States, 85050

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis | DecenTrialz